Study To Assess Long Term Safety Of Pazopanib

Summary

This study was a rollover study to evaluate the long term safety of pazopanib and to continue to provide pazopanib to patients who participated in a GSK sponsored pazopanib study until pazopanib is available commercially.

Timeline

Start

2006-06-20

Primary completion

2013-02-13

Completion

2018-03-08

Drugs

Indications